Clinical Trial: Phase I Clinical Study of MWN109 Tablets in Healthy Chinese Participants

U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07787611) titled 'Phase I Clinical Study of MWN109 Tablets in Healthy Chinese Participants' on Aug. 24.

Brief Summary: This is a randomized, double-blind, placebo-controlled, Phase 1 clinical study conducted in China to evaluate the safety, tolerability, pharmacokinetic (PK), and the effect of meal timing following single and multiple oral doses of MWN109 tablets in Chinese participants.

The study consists of a single ascending dose (SAD) part and a multiple ascending dose (MAD) part. The SAD part includes 6 dose cohorts, with further evaluation of the effects of different meal-timing conditions at a selected dose level. The MAD part includes 4 dose...